中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2015年
3期
410-415
,共6页
沈悦%马海英%张彦升%王娟%时炳正
瀋悅%馬海英%張彥升%王娟%時炳正
침열%마해영%장언승%왕연%시병정
生物材料%骨生物材料%单侧完全性腭裂%自体髂骨植骨%复合生物材料植骨%羟基磷灰石%重组人骨形成蛋白2
生物材料%骨生物材料%單側完全性腭裂%自體髂骨植骨%複閤生物材料植骨%羥基燐灰石%重組人骨形成蛋白2
생물재료%골생물재료%단측완전성악렬%자체가골식골%복합생물재료식골%간기린회석%중조인골형성단백2
Subject headings:Cleft Palate%Hydroxyapatites%Bone Morphogenetic Proteins
背景:已有研究证实胶原-羟基磷灰石复合重组人骨形成蛋白2植骨效果较好,然而尚未有文献报道此复合材料与自体骨移植效果的对比评价。
<br> 目的:检测自体髂骨移植与胶原-羟基磷灰石复合重组人骨形成蛋白2植骨在单侧完全性腭裂大鼠模型中的愈合效果。
<br> 方法:首先建立32只SD大鼠单侧完全性腭裂模型,随机均分为两组,对照组于裂隙处移植自体髂骨,实验组移植胶原-羟基磷灰石复合重组人骨形成蛋白2生物材料,于移植后的第1,2,3,4周,检测血清中碱性磷酸酶和抗酒石酸酸性磷酸酶活性、新生上腭骨骨密度、成骨细胞特异性标志物骨钙素、骨保护素、核心结合因子及破骨细胞特异性标志物破骨细胞分化因子等基因的表达。
<br> 结果与结论:随时间的推移,碱性磷酸酶活性逐渐升高,抗酒石酸酸性磷酸酶活性逐渐降低,实验组碱性磷酸酶活性始终高于对照组(P<0.05,P<0.01),抗酒石酸酸性磷酸酶活性始终低于对照组(P <0.05,P <0.01);骨密度逐渐增高,实验组始终高于对照组(P <0.01);骨钙素、骨保护素、核心结合因子基因水平逐渐上升,实验组始终高于对照组;破骨细胞分化因子逐渐降低,实验组始终低于对照组。表明胶原-羟基磷灰石复合重组人骨形成蛋白2复合生物材料植骨方式较自体植骨方式更有优势。
揹景:已有研究證實膠原-羥基燐灰石複閤重組人骨形成蛋白2植骨效果較好,然而尚未有文獻報道此複閤材料與自體骨移植效果的對比評價。
<br> 目的:檢測自體髂骨移植與膠原-羥基燐灰石複閤重組人骨形成蛋白2植骨在單側完全性腭裂大鼠模型中的愈閤效果。
<br> 方法:首先建立32隻SD大鼠單側完全性腭裂模型,隨機均分為兩組,對照組于裂隙處移植自體髂骨,實驗組移植膠原-羥基燐灰石複閤重組人骨形成蛋白2生物材料,于移植後的第1,2,3,4週,檢測血清中堿性燐痠酶和抗酒石痠痠性燐痠酶活性、新生上腭骨骨密度、成骨細胞特異性標誌物骨鈣素、骨保護素、覈心結閤因子及破骨細胞特異性標誌物破骨細胞分化因子等基因的錶達。
<br> 結果與結論:隨時間的推移,堿性燐痠酶活性逐漸升高,抗酒石痠痠性燐痠酶活性逐漸降低,實驗組堿性燐痠酶活性始終高于對照組(P<0.05,P<0.01),抗酒石痠痠性燐痠酶活性始終低于對照組(P <0.05,P <0.01);骨密度逐漸增高,實驗組始終高于對照組(P <0.01);骨鈣素、骨保護素、覈心結閤因子基因水平逐漸上升,實驗組始終高于對照組;破骨細胞分化因子逐漸降低,實驗組始終低于對照組。錶明膠原-羥基燐灰石複閤重組人骨形成蛋白2複閤生物材料植骨方式較自體植骨方式更有優勢。
배경:이유연구증실효원-간기린회석복합중조인골형성단백2식골효과교호,연이상미유문헌보도차복합재료여자체골이식효과적대비평개。
<br> 목적:검측자체가골이식여효원-간기린회석복합중조인골형성단백2식골재단측완전성악렬대서모형중적유합효과。
<br> 방법:수선건립32지SD대서단측완전성악렬모형,수궤균분위량조,대조조우렬극처이식자체가골,실험조이식효원-간기린회석복합중조인골형성단백2생물재료,우이식후적제1,2,3,4주,검측혈청중감성린산매화항주석산산성린산매활성、신생상악골골밀도、성골세포특이성표지물골개소、골보호소、핵심결합인자급파골세포특이성표지물파골세포분화인자등기인적표체。
<br> 결과여결론:수시간적추이,감성린산매활성축점승고,항주석산산성린산매활성축점강저,실험조감성린산매활성시종고우대조조(P<0.05,P<0.01),항주석산산성린산매활성시종저우대조조(P <0.05,P <0.01);골밀도축점증고,실험조시종고우대조조(P <0.01);골개소、골보호소、핵심결합인자기인수평축점상승,실험조시종고우대조조;파골세포분화인자축점강저,실험조시종저우대조조。표명효원-간기린회석복합중조인골형성단백2복합생물재료식골방식교자체식골방식경유우세。
BACKGROUND:It has been demonstrated that the effect of colagen/hydroxyapatite/recombinant human bone morphogenetic protein-2 composite graft is good, but there is no comparative analysis of this composite graft and autologous bone graft.
<br> OBJECTIVE:To detect the healing effect of autologous bone graft versus colagen/hydroxyapatite/recombinant human bone morphogenetic protein-2 composite graft in a rat model of unilateral complete cleft palate.
<br> METHODS: Firstly, we established the artificial unilateral complete cleft palate models in 32 Sprague-Dawley rats, and then the established animal models were randomly divided into control group and experimental group. The autologous iliac bone was transplanted into the fissures of control group, and the experimental group received colagen/hydroxyapatite/recombinant human bone morphogenetic protein-2 composite graft. After that, the activities of serum alkaline phosphatase and tartrate-resistant acid phosphatase, bone mineral densities in the neonatal palate, expressions of osteocalcin, osteoprotegerin, core binding factor, and osteoclast differentiation factor were detected at 1, 2, 3, 4 weeks after treatment.
<br> RESULTS AND CONCLUSION: Over time, the alkaline phosphatase activity increased gradualy, while tartrate-resistant acid phosphatase activity decreased. Compared with the control group, the alkaline phosphatase activity was always higher (P < 0.05,P < 0.01) but the tartrate-resistant acid phosphatase activity was lower in the experimental group (P < 0.05,P < 0.01); the bone mineral density increased in both groups, but it was always higher in the experimental group than the control group (P < 0.01). The expression levels of osteocalcin, osteoprotegerin, and core-binding factor gene gradualy rose in both groups, but they were always higher in the experimental group than the control group; in contrast, the expression of osteoclast differentiation factor was decreased in both groups, and it was lower in the experimental group than the control group. These findings indicate that the colagen/hydroxyapatite/recombinant human bone morphogenetic protein-2 composite graft has more advantages compared with bone autograft.